Molecular cloning and structural characterization of the rat thymosin β15 gene

被引:9
作者
Bao, L
Zetter, BR
机构
[1] Harvard Univ, Childrens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA
[2] Harvard Univ, Childrens Hosp, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
gene structure; metastasis; promoter; prostate; thymosin beta 15;
D O I
10.1016/S0378-1119(00)00452-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Thymosin beta 15 is expressed in metastatic variants of Dunning rat prostatic carcinoma but not in a nonmetastatic variant. It is also upregulated in malignant human prostate cancers and was shown to be a predictive marker for patient outcome in prostate cancer. To explore the molecular mechanism of transcriptional regulation of thymosin beta 15, we isolated and characterized the rat thymosin beta 15 gene. The gene appears to exist as a single copy in the rat genome and to comprise three exons distributed over 2 kb. The transcription start site was defined by primer extension analysis at 30 bp upstream of the translation start site. Sequence analysis of the 5'-flanking region of the transcription start site revealed properties consistent with promoter activity. The promoter region is GC rich and contains numerous consensus transcription factor binding sites as well as a GC box, but no TATA box. The transcriptional activity of the 5'-flanking region was analyzed by transient transfection of rat prostate cancer cells with firefly luciferase-encoding gene expression vector constructs. The isolated 5' region showed significant promoter activity. The identification of the thymosin beta 15 promoter could aid our understanding of the regulation of this gene and its enhanced expression in human cancer. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 24 条
[1]   Thymosin β15 expression in tumor cell lines with varying metastatic potential [J].
Bao, L ;
Loda, M ;
Zetter, BR .
CLINICAL & EXPERIMENTAL METASTASIS, 1998, 16 (03) :227-233
[2]   Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer [J].
Bao, LR ;
Loda, M ;
Janmey, PA ;
Stewart, R ;
AnandApte, B ;
Zetter, BR .
NATURE MEDICINE, 1996, 2 (12) :1322-1328
[3]  
BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025
[4]   THYMOSIN-BETA(4) SEQUESTERS THE MAJORITY OF G-ACTIN IN RESTING HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
CASSIMERIS, L ;
SAFER, D ;
NACHMIAS, VT ;
ZIGMOND, SH .
JOURNAL OF CELL BIOLOGY, 1992, 119 (05) :1261-1270
[5]   Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer - Results from a pilot study [J].
Chakravarti, A ;
Zehr, EM ;
Zietman, AL ;
Shipley, WU ;
Goggins, WB ;
Finkelstein, DM ;
Young, RH ;
Chang, EL ;
Wu, CL .
UROLOGY, 2000, 55 (05) :635-638
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P157
[7]   Genomic organization of the human KAl1 metastasis-suppressor gene [J].
Dong, JT ;
Isaacs, WB ;
Barrett, JC ;
Isaacs, JT .
GENOMICS, 1997, 41 (01) :25-32
[8]  
HYUN SW, 1994, J BIOL CHEM, V269, P364
[9]   ESTABLISHMENT AND CHARACTERIZATION OF 7 DUNNING RAT PROSTATIC-CANCER CELL-LINES AND THEIR USE IN DEVELOPING METHODS FOR PREDICTING METASTATIC ABILITIES OF PROSTATIC CANCERS [J].
ISAACS, JT ;
ISAACS, WB ;
FEITZ, WFJ ;
SCHERES, J .
PROSTATE, 1986, 9 (03) :261-281
[10]  
Jackers P, 1996, ONCOGENE, V13, P495